New York, NY – September 24, 2019 – Berkery Noyes is pleased to announce that it represented RxStrategies in its acquisition by a mid-market private equity firm. RxStrategies provides innovative solutions that assist in meeting regulatory compliance, patient eligibility, pharmacy replenishment, program tracking, and reporting under the Federal 340B Program. The Company’s technology solutions allow health systems, hospitals, and clinics to gain access to discounted prices on prescription drugs.

RxStrategies is a technology leader in the 340B contract pharmacy and mixed use (Split Billing) markets due to its robust technology platform, business intelligence, and cloud-based analytics tools. Through a deep understanding of the 340B regulatory dynamic, with a unique focus on compliance, RxStrategies delivers a hard dollar value proposition to its clients both in terms of time saved and maximum 340B utilization.

Berkery Noyes served as the exclusive financial advisor to RxStrategies in this transaction.

About Berkery Noyes

Berkery Noyes provides strategic mergers and acquisitions (M&A) transaction advisory services to middle-market healthcare, tech-enabled business and information companies in the United States and internationally. The firm primarily advises privately or family owned companies in addition to private equity firms in the sales of portfolio companies and strategic companies in divestures. A sample of recent deals include Medimix International in its sale to Evidera; TGas Advisors in its sale to Trinity Partners; PolicyMedical in its sale to iContracts; Continuing Education Alliance and Practicing Clinicians Exchange in their sale to Renovus Capital Partners; Amazing Charts in its sale to Harris Computer; Verisys’ shareholders on the Company’s sale to Spectrum Equity and Cressey & Company; ConnexionPoint on its growth investment from VSS; Panacea Healthcare Solutions in the sale of the company’s Revenue Capture and Coding and Documentation Division to CareerStep/Revelstoke Equity; The Wellness Network in its sale to Wafra Partners; HMP Communications Holdings, LLC in the recapitalization of its business by Susquehanna; and Medworxx Solutions in its sale to Aptean. For more information, please visit